Skip to main content
. 2017 Sep 5;12(9):e0183813. doi: 10.1371/journal.pone.0183813

Table 6. Subgroup analysis of the relationship between current use of fluoroquinolones and risk of composite gastric or intestinal perforation.

Patient subgroups Disease Risk Score adjusted RR
(95% Confidence interval)
Fluoroquinolone user
v.s. non-user
>70 years of age 1.94 (1.49–2.52)***
< = 70 years of age 1.88 (1.55–2.29) ***
Male 1.84 (1.45–2.32) ***
Female 1.94 (1.57–2.40) ***

*** refers to p<0.001

RR refers to rate ratio.